![Audit: Lynda Chin's abandoned $62 million IBM Watson collaboration didn't follow standard procedures](https://cdn.cancerletter.com/media/2017/02/burning-money-web.jpg)
![Audit: Lynda Chin's abandoned $62 million IBM Watson collaboration didn't follow standard procedures](https://cdn.cancerletter.com/media/2017/02/burning-money-web.jpg)
Cover Story
Audit: Lynda Chin's abandoned $62 million IBM Watson collaboration didn't follow standard procedures
By Paul Goldberg and Matthew Bin Han Ong
An audit of an abandoned mega-project run by IBM Watson and MD Anderson Cancer Center found that the Houston-based institution skirted the UT System's procurement regulations as it spent $62.1 million on an ill-fated artificial intelligence system.
In Brief
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
Funding Opportunities
Drugs & Targets
Trending Stories
- When tobacco companies sponsored the Olympics
- U.S. News rankings for cancer hospitals shift again with inclusion of Medicare Advantage data
Rankings now include a list of Best Regional Hospitals for Equitable Access - How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- Kamala Harris widely expected to continue Cancer Moonshot; Conservatives present their vision in Project 2025
- Cancer Moonshot contributes additional $100M to reduce cancer burden in Africa
- Robert Gallo named founding director of Microbial Oncology Program at TGH Cancer Institute